Literature DB >> 5097569

The source of plasma dihydrotestosterone in man.

T Ito, R Horton.   

Abstract

The source of plasma dihydrotestosterone (DHT) (17beta-hydroxy-5alpha-androstan-3-one) in humans has been investigated by infusing two potential peripheral precursors, testosterone (T) and androstenedione (A). Metabolic clearance rates (MCR), conversion ratios (CR), transfer constants (rho), and blood production rates (P(B)) were calculated. Plasma testosterone and dihydrotestosterone were measured by competitive binding techniques. The MCR(DHT) was 652 +/-35 (SD) liters/day in five males and 314 +/-63 (SD) liters/day in four adult females. In each individual, the MCR(DHT) was significantly lower than MCR(T) as predicted by testosterone-binding protein affinity studies. The P(B) (DHT) was 302 +/-65 (SD) mug/day in males and 56 +/-26 mug/day in females. Testosterone and androstenedione are precursors (prehormones) for plasma dihydrotestosterone. The conversion ratio CR(BB) (T-DHT), calculated as the ratio of counts per minute per liter of plasma of product to precursor after infusion of labeled precursor, was 5.6 +/-0.6 (SD)% (six subjects) in the male and 3.5 +/-0.4 (SD)% (four subjects) in the female. CR(BB) (A-DHT) after androstenedione infusion to three female subjects averaged 9.2%. No dihydrotestosterone back conversion was detected (< 0.2%). The transfer constants were [rho]BB(T-DHT), 3.9 +/-1.0% (male) and 1.7 +/-0.6% (female), and [rho]BB(A-DHT) average was 13.3% in three female subjects. Using either plasma testosterone and dihydrotestosterone values from our subjects and mean androstenedione values as reported in the literature, approximate contributions can be calculated. Testosterone conversion accounts for at least 70% of plasma DHT in the male, but less than 20% in the normal female. Androstenedione appears to be a major prehormone of plasma dihydrotestosterone accounting for at least two-thirds plasma dihydrotestosterone by peripheral conversion in adult females. In three normal women undergoing tubal ligation, there was an unimpressive gradient between ovarian vein and peripheral plasma dihydrotestosterone. It is suggested that dihydrotestosterone in the blood does not arise from direct secretion but may reflect events occurring in peripheral androgen target tissues.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5097569      PMCID: PMC442061          DOI: 10.1172/JCI106650

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.

Authors:  R Horton; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

2.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

Review 3.  Steroid dynamics under steady-state conditions.

Authors:  D T Baird; R Horton; C Longcope; J F Tait
Journal:  Recent Prog Horm Res       Date:  1969

4.  Dihydrotestosterone in human peripheral plasma.

Authors:  T Ito; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1970-10       Impact factor: 5.958

5.  Comparative binding affinity of estrogens and its relation to estrogenic potency.

Authors:  S G Korenman
Journal:  Steroids       Date:  1969-02       Impact factor: 2.668

6.  Testosterone assays by competitive protein binding.

Authors:  A Vermeulen; L Verdonck
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1970

7.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

8.  Metabolic clearance rates and interconversions of estrone and 17beta-estradiol in normal males and females.

Authors:  C Longcope; D S Layne; J F Tait
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

9.  A comparative study of the conversion of testosterone to 17-beta-hydroxy-5-alpha-androstan-3-one (Dihydrotestosterone) by prostate and epididymis.

Authors:  R E Gloyna; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

10.  Conversion of blood androgens to estrogens in normal adult men and women.

Authors:  C Longcope; T Kato; R Horton
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  21 in total

Review 1.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

2.  5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.

Authors:  C-H Chou; C-L Lin; M-C Lin; F-C Sung; C-H Kao
Journal:  J Endocrinol Invest       Date:  2015-03-17       Impact factor: 4.256

3.  Klinefelter's syndrome: a study of its hormonal plasma pattern.

Authors:  G Forti; G Giusti; A Borghi; M Pazzagli; G Fiorelli; E Cabresi; M Mannelli; F Bassi; P Giannotti; S Fusi; M Serio
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

4.  Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men?

Authors:  R J Santen
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

Review 5.  Adverse effects of common medications on male fertility.

Authors:  Mary K Samplaski; Ajay K Nangia
Journal:  Nat Rev Urol       Date:  2015-06-23       Impact factor: 14.432

6.  Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.

Authors:  J D Veldhuis; A D Rogol; E Samojlik; N H Ertel
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Testosterone and estradiol are co-secreted episodically by the human testis.

Authors:  S J Winters; P Troen
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Testosterone metabolism by the rat gastrointestinal tract, in vitro and in vivo.

Authors:  M J Farthing; G P Vinson; C R Edwards; A M Dawson
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

9.  3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.

Authors:  R Horton; D Hawks; R Lobo
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

10.  Estrogen and androgen dynamics in liver disease.

Authors:  C Longcope; J H Pratt; S Schneider; E Fineberg
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.